Dld Asset Management, LP Alnylam Pharmaceuticals, Inc. Transaction History
Dld Asset Management, LP
- $161 Million
- Q2 2024
A detailed history of Dld Asset Management, LP transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Dld Asset Management, LP holds 16,200 shares of ALNY stock, worth $4.56 Million. This represents 2.45% of its overall portfolio holdings.
Number of Shares
16,200
Previous 10,000
62.0%
Holding current value
$4.56 Million
Previous $1.49 Million
163.45%
% of portfolio
2.45%
Previous 1.21%
Shares
1 transactions
Others Institutions Holding ALNY
# of Institutions
636Shares Held
108MCall Options Held
2.33MPut Options Held
2.15M-
Capital World Investors Los Angeles, CA15MShares$4.22 Billion0.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.5MShares$3.52 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.69 Billion0.05% of portfolio
-
Wellington Management Group LLP Boston, MA6.21MShares$1.75 Billion0.28% of portfolio
-
Baillie Gifford & CO6.03MShares$1.7 Billion1.16% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $34.6B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...